![](https://www.nemera.net/wp-content/uploads/2024/06/Post-ESG-report.png)
Our 2023 ESG report is published!
05/06/2024
Read our 2023 ESG report to know more where we stand today on sustainability, our strategic priorities and objectives
Continue Reading05/06/2024
Read our 2023 ESG report to know more where we stand today on sustainability, our strategic priorities and objectives
Continue Reading28/02/2024
The Index, is calculated from 4 to 5 indicators depending on whether the company has less or more than 250 employees and takes into account
Continue Reading30/01/2024
Cristalia’s human growth hormone will be administered with CRISPEN®. Approved by ANVISA1, CRISPEN® is part of Nemera’s state-of-the-art pen injector platform PENDURA AD.
Continue ReadingWe are here to help!